Related Experiment Video
Updated: May 8, 2026
09:15
Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
Islet autoimmunity in phenotypic type 2 diabetes patients
B Brooks-Worrell1, R Narla, J P Palmer
1Department of Medicine, University of Washington, Seattle, WA, USA. bbrooks@u.washington.edu
Diabetes, Obesity & Metabolism
|September 6, 2013
Summary
Type 2 diabetes (T2D) involves chronic inflammation and islet autoimmunity, similar to type 1 diabetes (T1D). This cell-mediated autoimmune disease contributes to beta-cell dysfunction and T2D progression.
Area of Science:
- Immunology
- Endocrinology
- Metabolic Diseases
Background:
- Type 2 diabetes (T2D) was historically viewed as a metabolic disease of aging.
- Emerging evidence highlights chronic systemic inflammation's role in insulin resistance and T2D development.
- Investigations reveal islet-specific T cells and autoimmune disease in T2D patients.
Purpose of the Study:
- To discuss the role of cell-mediated islet autoimmune disease in T2D progression.
- To explore similarities in islet-specific T-cell reactivity between T1D and T2D.
- To provide insights into the pathophysiology of T2D.
Main Methods:
- Literature review and synthesis of existing research.
- Analysis of immunological findings in T2D patients.
- Comparative analysis of T-cell responses in T1D and T2D.
Main Results:
- Cell-mediated islet autoimmunity is implicated in the pathogenesis of T2D.
- Progressive loss of beta-cell function in T2D correlates with islet autoimmunity.
- Shared T-cell reactivity patterns observed between T1D and T2D.
Conclusions:
- Islet autoimmunity is a significant factor in T2D progression.
- T2D shares immunological mechanisms with T1D, particularly T-cell mediated autoimmunity.
- Understanding these shared pathways may offer new therapeutic targets for T2D.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...